It would seem to be a waste of money paying for an updated feasibility study on a project you are going to only own 42% of. So yes Kruiser Ithink the jv is in trouble.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
I88 History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OCC Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
